Alnylam Pharmaceuticals Revenue, Growth & Competitor Profile

Company Profile & Annual Report for Alnylam Pharmaceuticals

Access the complete profile.

Alnylam Pharmaceuticals Fast Facts

Revenue	$100 - $500 million    See Exact Annual Revenue
Employees	Over 1,000Exact Company Size
Primary Industry	5417 Scientific Research & Development Services
Additional NAICS Codes	325412 Pharmaceutical Preparation Manufacturing 541711 Research & Development in Biotechnology
Address	675 West Kendall Street Cambridge, MA 02142

Note: Revenues for privately held companies are statistical evaluations.


Alnylam Pharmaceuticals's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Alnylam Pharmaceuticals's annual revenues are $100 - $500 million (see exact revenue data)
• What industry is the company in?
  • Alnylam Pharmaceuticals is classified as operating in the Scientific Research & Development Services industry, NAICS Code 5417.

Alnylam Pharmaceuticals Annual Revenue and Growth Rate

Alnylam Pharmaceuticals	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2025	$100 - $500 million Details in Premium Report
2024
2023
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Alnylam Pharmaceuticals's revenues are gauged from an analysis of company filings.

Alnylam Pharmaceuticals's Income Statement (based on Industry Averages)

Alnylam Pharmaceuticals P&L	$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Trademark Applications

Trademark applications show the products and services that Alnylam Pharmaceuticals is developing and marketing. Alnylam Pharmaceuticals doesn't have any recent trademark applications, indicating Alnylam Pharmaceuticals is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
THE BRIDGE Education services in the medical field for medical professionals, patients and their families, namely, conducting live onsite seminars, providing on-demand, non-downloadable video classes, and providing one-on-one and family tutoring; educational services, namely, conducting live onsite seminars, providing on-demand non-downloadable video classes, and providing one-on-one and family tutoring, for training medical professionals and patients regarding amyloidosis, and distributing course materials in connection therewith	03/30/2023
ELEVATE Maintaining a clinical registry database for patients with genetic mutations that cause enzyme defects and acute hepatic porphyria; maintaining a registry on the clinical outcomes of acute hepatic porphyria in patients over time	04/23/2021
BONAPH1DE Maintaining a clinical registry database for patients with inherited disorders of the liver and primary hyperoxaluria; maintaining a registry on the clinical outcomes of primary hyperoxaluria in patients over time	04/23/2021

See all trademarks and details in the Full Report.

Market Share of Alnylam Pharmaceuticals's Largest Competitors

A competitive analysis shows these companies are in the same general field as Alnylam Pharmaceuticals, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
LEIDOS	Denver, CO	100
NATIONAL TECHNOLOGY & ENGINEERING SOLUTIONS OF SANDIA	Albuquerque, NM	30
INC RESEARCH	Raleigh, NC	27
RESEARCH FOUNDATION FOR STATE UNIVERSITY OF NEW YORK	Albany, NY	17
FLUOR MARINE PROPULSION	West Mifflin, PA	15
SYNEOS HEALTH	Raleigh, NC	13
ILLUMINA	San Diego, CA	12
UT-BATTELLE	Oak Ridge, TN	11
PRA HOLDINGS	Raleigh, NC	11

Nearby Competitors

These companies are similar in business line and location to Alnylam Pharmaceuticals. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
BROAD INSTITUTE	Cambridge, MA	100
BEIGENE USA	Cambridge, MA	69
ALNYLAM PHARMACEUTICALS	Cambridge, MA	52
SAGE THERAPEUTICS	Cambridge, MA	47
INTELLIA THERAPEUTICS	Cambridge, MA	35
IPSEN BIOPHARMACEUTICALS	Cambridge, MA	34

Other Companies at 675 West Kendall Street, Cambridge MA

Company	Headquarters	Revenue ($ MM)
C4 THERAPEUTICS	Cambridge, MA	100
MOMENTA PHARMACEUTICALS	Cambridge, MA	82

Future Competition: Alnylam Pharmaceuticals's Fastest Growing Competitors

These companies are in the same general field as Alnylam Pharmaceuticals and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)